Treatment and Research on VITT and Platelet Factor 4 Antibodies

This chapter discusses the use of IVIG, human antibodies, and anticoagulants like Funder Perinox in treating Vaccine-Induced Thrombotic Thrombocytopenia (VITT), as well as the research on platelet factor 4 antibodies and genetic predisposition in VITT patients and individuals with fatal blood diseases triggered by adenovirus.